Monoxidil + RU5841 + Finesteride
A blend of finasteride (500mcg), minoxidil (10%), and RU58841 (25mg) offers a potent, multi-mechanistic approach to treating male pattern baldness by simultaneously reducing DHT (via finasteride and RU58841) and stimulating growth (via minoxidil).
This combination targets hair loss at the root, reduces follicle miniaturization, increases hair density, and promotes thicker hair.
Prospective Benefits:
Triple-Action Mechanism: The mixture combines three distinct actions: blocking DHT production (finasteride), blocking DHT binding to receptors (RU58841), and increasing scalp blood flow to stimulate follicles (minoxidil).
Increased Hair Density and Thickness: This combination is designed to improve overall hair volume, density, and thickness more effectively than single-agent treatments.
Synergistic Growth Stimulation: While minoxidil reactivates dormant follicles, the anti-androgens (finasteride and RU58841) ensure the new hair is not immediately affected by DHT, allowing for sustainable growth.
Potential for Faster Results: Studies on finasteride and minoxidil indicate visible improvements in hair growth can occur as early as 3 months.
Alternative for Refractory Cases: For individuals who have not seen success with standard treatments, the addition of RU58841 (a potent, non-approved investigational compound) may offer further inhibition of hair loss.
All peptide sales are non‑refundable and non‑returnable. However, your satisfaction is important to us — if there is any problem with your order, please contact us right away and we will work with you to make it right.
Peptide therapies are for research wellness support only and are not intended to diagnose, treat, cure, or prevent any disease.
